In The News Posted January 3, 2022 Share Posted January 3, 2022 NEW YORK, Jan. 3, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons and entities that purchased or otherwise acquired: (a) Silverback Therapeutics, Inc. ("Silverback" or the "Company") (NASDAQ: SBTX) common stock pursuant and/or...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now